SU-E-T-430: Evaluation of Inverse Optimization in Brachytherapy for Locally Advanced Cervix Cancer

Medical Physics
Y LiaoK Kiel

Abstract

Brachytherapy is a vital part of treating locally advanced cervix cancer. Point-based 2D treatment planning is conventionally used. New CT/MRI-compatible applicators for HDR brachytherapy make 3D conformal planning possible. GEC-ESTRO endorsed the EMBRACE (intErnational study on MRI-guided BRachytherapy in locally Advanced CErvical cancer) protocol which recommends standard-plan-based manual optimization over inverse optimization due to the concern of the uncertainty of high dose in targets and adjacent normal tissue. This study investigated the feasibility of inverse optimization planning. Eight cervix cases using tandem/ring applicators +/- parametrial needles were evaluated. Both manually and inversely optimized 3D conformal plans using Oncentra® Brachy were generated for each case following EMBRACE guidelines. Planning time and DVH parameters including D90 and V100% for HR-CTV, D90 for IR-CTV, D2cc for normal structures (bladder, rectum, sigmoid colon, and small bowel) were compared. Dose was reported in total EQD2 dose, assuming 45Gy in 25 fractions external beam and 28Gy in 4 fractions HDR treatment. Prescription dose (PD) and PD×2 isodose volumes and V100% and V200% for normal tissue (excluding all contoured OARs) were c...Continue Reading

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.